Identification of GRO1 as a critical determinant for mutant p53 gain of function.
about
The rebel angel: mutant p53 as the driving oncogene in breast cancer.Arsenic trioxide reactivates proteasome-dependent degradation of mutant p53 protein in cancer cells in part via enhanced expression of Pirh2 E3 ligaseThe Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesTGF-β Negatively Regulates CXCL1 Chemokine Expression in Mammary Fibroblasts through Enhancement of Smad2/3 and Suppression of HGF/c-Met Signaling MechanismsMutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5.Antiproliferative and proapoptotic activity of GUT-70 mediated through potent inhibition of Hsp90 in mantle cell lymphomaMass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location.Mutant p53 gain-of-function in cancer.Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of functionCharacterization of functional domains necessary for mutant p53 gain of function.Poly (C)-binding protein 1 regulates p63 expression through mRNA stability.Mutant p53 disrupts MCF-10A cell polarity in three-dimensional culture via epithelial-to-mesenchymal transitions.Mutant p53 protein is targeted by arsenic for degradation and plays a role in arsenic-mediated growth suppression.High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H.ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancersMutant p53 cooperates with ETS2 to promote etoposide resistance.Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8.Mutant p53: one name, many proteins.The consequence of oncomorphic TP53 mutations in ovarian cancer.Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells.Mutant p53 in cancer: new functions and therapeutic opportunities.Oncogenic Mutant p53 Gain of Function Nourishes the Vicious Cycle of Tumor Development and Cancer Stem-Cell Formation.Transcriptional Regulation by Wild-Type and Cancer-Related Mutant Forms of p53.p73 expression is regulated by RNPC1, a target of the p53 family, via mRNA stabilityMutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells.NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.
P2860
Q27686765-780297DC-1464-4D39-8B5A-43BA0BF6D18AQ28541801-BE0715EE-38A2-4DF2-9BD3-D5B96E2BDA48Q28546913-7D3562F1-6ECB-4AE9-974E-BD56E55A748EQ28547113-0CE80ED7-C152-42A2-9164-D7E065404C56Q30313610-337D5F7B-ECC0-4267-80F5-FC2C9FAD0A86Q30498194-63856FB3-28D4-4F3C-A3C5-D9C87C5C9C98Q31048838-254F6A4A-C91F-4476-AAB1-057CDDBCA656Q33687048-C26C221C-1ED3-4247-9974-159567CED27EQ33825046-67A9BBD4-88F5-4DFC-89C2-CC08A373A8ABQ33825155-3D4712DE-F988-45B0-A0BE-C0EB3DDCDD6BQ34938075-0F052DAB-CE5F-47E6-BB02-619B09D312E5Q34963520-C2675BB3-24DF-471E-8FDA-980C73619283Q34978872-15DB4B26-A185-4ACA-871E-B851C7D52B05Q35078954-A9A35158-1CDB-4C37-92AF-192C9864F97AQ35501591-622FD47F-614D-47F7-BB51-452B00587946Q35914917-15BF25C8-D979-4F01-9B7E-FA6D165131C7Q36019774-E3333A42-C919-4366-BDF3-A7620F2D8067Q36070574-59132772-A37F-4AA6-9C04-5E70A529C733Q37225303-E9FA5900-771E-40D5-9A99-8ED377BB7ECEQ37423073-960007FA-FF43-4457-9F6B-B5E9D4259F4AQ38197826-9F730B2C-905C-4291-80EA-D78A4C8C50FBQ38846785-5605DEED-9EBB-4A17-911B-398502154A44Q39005896-AFDDCA78-C299-4929-9330-353FEA053C7EQ39363650-036F19F3-A5AA-4C7B-98DB-4F12A9F4A0DAQ41490261-2FA2835C-B81B-4237-A6B1-5BEE32B8A058Q41585790-4170BC67-6F16-4C99-AC34-89ABFDD8CB51
P2860
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@en
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@nl
type
label
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@en
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@nl
prefLabel
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@en
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@nl
P2860
P356
P1476
Identification of GRO1 as a critical determinant for mutant p53 gain of function.
@en
P2093
Wensheng Yan
Xinbin Chen
P2860
P304
12178-12187
P356
10.1074/JBC.M900994200
P407
P577
2009-03-03T00:00:00Z